We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTF icon
826
Invesco Dorsey Wright Technology Momentum ETF
PTF
$513M
$693K ﹤0.01%
10,924
– –
BHP icon
827
BHP
BHP
$211B
$685K ﹤0.01%
11,034
-2,524
-19% -$139K
CBSH icon
828
Commerce Bancshares
CBSH
$8.68B
$684K ﹤0.01%
12,704
+355
+3% +$19.7K
XBI icon
829
State Street SPDR S&P Biotech ETF
XBI
$10B
$681K ﹤0.01%
6,893
+239
+4% +$23.5K
GL icon
830
Globe Life
GL
$14B
$681K ﹤0.01%
6,428
+447
+7% +$42.9K
TDW icon
831
Tidewater
TDW
$3.63B
$680K ﹤0.01%
9,479
+321
+4% +$28K
KNTK icon
832
Kinetik
KNTK
$3.72B
$679K ﹤0.01%
14,993
-1,800
-11% -$77.9K
KRG icon
833
Kite Realty
KRG
$5.86B
$677K ﹤0.01%
25,494
+37
+0.1% +$918
SAN icon
834
Banco Santander
SAN
$191B
$677K ﹤0.01%
132,664
-19,618
-13% -$94.3K
EQNR icon
835
Equinor
EQNR
$97.3B
$676K ﹤0.01%
26,707
+1,247
+5% +$32.9K
MTUM icon
836
iShares MSCI USA Momentum Factor ETF
MTUM
$23.6B
$675K ﹤0.01%
3,327
+928
+39% +$180K
PTGX icon
837
Protagonist Therapeutics
PTGX
$8.55B
$674K ﹤0.01%
14,981
-525
-3% -$21.2K
RELX icon
838
RELX
RELX
$66.8B
$674K ﹤0.01%
14,196
+405
+3% +$18.8K
AXSM icon
839
Axsome Therapeutics
AXSM
$11.7B
$672K ﹤0.01%
7,473
+70
+0.9% +$6.11K
HST icon
840
Host Hotels & Resorts
HST
$17.5B
$668K ﹤0.01%
37,946
-385,131
-91% -$6.69M
EIX icon
841
Edison International
EIX
$30.3B
$668K ﹤0.01%
7,668
+400
+6% +$32.5K
MFC icon
842
Manulife Financial
MFC
$73B
$666K ﹤0.01%
22,540
+4,780
+27% +$128K
PNR icon
843
Pentair
PNR
$10.8B
$666K ﹤0.01%
+6,809
New +$583K
VLTO icon
844
Veralto
VLTO
$24.3B
$665K ﹤0.01%
5,947
+465
+8% +$49.1K
ITRI icon
845
Itron
ITRI
$4.54B
$664K ﹤0.01%
6,220
+134
+2% +$13.6K
EPAC icon
846
Enerpac Tool Group
EPAC
$1.86B
$662K ﹤0.01%
15,810
+447
+3% +$17.9K
URBN icon
847
Urban Outfitters
URBN
$6.46B
$657K ﹤0.01%
17,159
+243
+1% +$9.88K
WTM icon
848
White Mountains Insurance
WTM
$5.33B
$651K ﹤0.01%
384
+7
+2% +$12.2K
SCHE icon
849
Schwab Emerging Markets Equity ETF
SCHE
$12.2B
$649K ﹤0.01%
22,254
– –
TD icon
850
Toronto Dominion Bank
TD
$193B
$644K ﹤0.01%
10,181
+1,195
+13% +$70.6K
32 33
34
35 36

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.